Key Highlights

  • Shares are trading at $125.19, up 8.48% in Thursday's session.
  • Directors Thomas Smach and Beth Kaplan both made recent insider purchases, including a $437,000 buy by Smach.
  • Bank of America raised its price target on the stock to $160.
  • The company guided to fiscal 2026 Earnings Per Share of $13.70 to $14.00, following a second-quarter beat.

Insider Buying and a Price Target Hike Extend the Rally

Crocs (NASDAQ:CROX) shares extended a multi-day rally in Thursday's session, driven by a wave of insider buying that includes Director Thomas Smach's $437,000 purchase alongside additional insider purchases by Director Beth Kaplan. Crocs is a Broomfield, Colorado-based footwear company that designs, develops, markets, and distributes casual lifestyle footwear and accessories under its namesake Crocs Brand and its HEYDUDE brand.

Bank of America also raised its price target on the stock to $160, adding to the bullish tone around the shares. The insider buying and analyst upgrade are helping offset lingering investor concerns tied to a recent stock sale by CEO Andrew Rees.

Strong Quarterly Results Set Up the Move

The rally follows a strong second-quarter report in which Crocs posted adjusted earnings per share of $4.55 against a $4.35 consensus estimate, with Revenue up 2.6% year over year to $1.18 billion. The company also guided to fiscal 2026 earnings per share of $13.70 to $14.00.

Investors Rotate Back Into a Beaten-Down Footwear Name

Investors appear to be rotating back into Crocs, which trades at a low forward multiple near 10 times earnings, even as broader apparel and footwear peers such as Lululemon (NASDAQ:LULU) and VF Corp (NYSE:VFC) continue to struggle and the sector digests this week's hawkish Federal Reserve rate hike and rising bond yields.

Guidance Execution Will Test the Rally's Durability

Crocs shares are climbing as insider confidence and improved analyst sentiment combine with a low valuation to draw investors back into the name. Continued execution against the company's fiscal 2026 guidance, along with any further insider transaction activity, will likely shape the stock's next move.